Insufficient scRNA-seq data for expression of IFNL3 at single-cell level.
Insufficient scRNA-seq data for expression of IFNL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 59% | 2.39 | 1561 / 2642 | 0% | 0 | 0 / 705 |
pancreas | 48% | 1.08 | 157 / 328 | 4% | 0.10 | 8 / 178 |
skin | 48% | 1.30 | 876 / 1809 | 0% | 0 | 0 / 472 |
uterus | 37% | 1.01 | 63 / 170 | 7% | 0.18 | 33 / 459 |
peripheral blood | 40% | 1.24 | 376 / 929 | 0% | 0 | 0 / 0 |
ovary | 26% | 0.66 | 46 / 180 | 8% | 0.20 | 36 / 430 |
lung | 27% | 0.44 | 154 / 578 | 3% | 0.07 | 38 / 1155 |
breast | 21% | 0.33 | 98 / 459 | 8% | 0.22 | 93 / 1118 |
spleen | 27% | 0.50 | 66 / 241 | 0% | 0 | 0 / 0 |
esophagus | 17% | 0.26 | 245 / 1445 | 5% | 0.42 | 10 / 183 |
intestine | 19% | 0.29 | 181 / 966 | 3% | 0.08 | 15 / 527 |
thymus | 19% | 0.31 | 125 / 653 | 0% | 0.01 | 2 / 605 |
stomach | 16% | 0.23 | 58 / 359 | 3% | 0.07 | 8 / 286 |
muscle | 18% | 0.23 | 146 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 18% | 0.25 | 240 / 1335 | 0% | 0 | 0 / 0 |
adipose | 17% | 0.26 | 207 / 1204 | 0% | 0 | 0 / 0 |
prostate | 14% | 0.20 | 34 / 245 | 0% | 0.01 | 2 / 502 |
bladder | 10% | 0.14 | 2 / 21 | 4% | 0.10 | 18 / 504 |
adrenal gland | 12% | 0.18 | 32 / 258 | 0% | 0 | 0 / 230 |
liver | 12% | 0.16 | 26 / 226 | 0% | 0 | 0 / 406 |
kidney | 10% | 0.13 | 9 / 89 | 0% | 0 | 0 / 901 |
heart | 10% | 0.11 | 82 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.15 | 3 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0098586 | Biological process | cellular response to virus |
GO_0050778 | Biological process | positive regulation of immune response |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0038196 | Biological process | type III interferon-mediated signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IFNL3 |
Protein name | Interferon lambda 3 (Interleukin 28B (Interferon, lambda 3)) Interferon lambda-3 (IFN-lambda-3) (Cytokine Zcyto22) (Interleukin-28B) (IL-28B) (Interleukin-28C) (IL-28C) |
Synonyms | IL28B IL28C ZCYTO22 hCG_1997257 |
Description | FUNCTION: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression. . |
Accessions | ENST00000413851.3 A0A0C4DGW8 Q8IZI9 ENST00000613087.5 ENST00000709043.1 |